Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data

Autor: Philip J. Rosenfeld, Alexander J. Brucker, Lawrence J. Singerman, Lawrence A. Yannuzzi, Usha Chakravarthy, Robyn H. Guymer, Ursula Schmidt-Erfurth, Giovanni Staurenghi, Glenn J. Jaffe, David S. Boyer, Caroline R. Baumal, Kyoko Ohno-Matsui, Srinivas R. Sadda, David J. Wilson, David Sarraf, Emily Y. Chew, Frank G. Holz, Ramin Tadayoni, Jordi Monés, Alain Gaudric, Barbara A Blodi, Steffen Schmitz-Valckenberg, Eric H. Souied, K. Bailey Freund, Giuseppe Querques, Salomon Y. Cohen, Nadia K. Waheed, Gabriel Coscas, Richard F. Spaide, Karl G. Csaky, James G. Fujimoto, Xiaoxin Li, Hans E. Grossniklaus, Phil Luthert, Daniel Pauleikhoff
Přispěvatelé: Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
Rok vydání: 2020
Předmět:
Zdroj: Elsevier
ISSN: 0161-6420
DOI: 10.1016/j.ophtha.2019.11.004
Popis: Purpose To establish a process to evaluate and standardize a state-of-the-art nomenclature for reporting neovascular age-related macular degeneration (AMD) data. Design Consensus meeting. Participants An international panel of retina specialists, imaging and image reading center experts, and ocular pathologists. Methods During several meetings organized under the auspices of the Macula Society, an international study group discussed and codified a set nomenclature framework for classifying the subtypes of neovascular AMD and associated lesion components. Main Outcome Measures A consensus classification of neovascular AMD. Results The study group created a standardized working definition of AMD. The components of neovascular AMD were defined and subclassified. Disease consequences of macular neovascularization were delineated. Conclusions The framework of a consensus nomenclature system, a definition of AMD, and a delineation of the subtypes of neovascular AMD were developed. Establishing a uniform set of definitions will facilitate comparison of diverse patient groups and different studies. The framework presented is modified and updated readily, processes that are anticipated to occur on a periodic basis. The study group suggests that the consensus standards outlined in this article be used in future reported studies of neovascular AMD and clinical practice.
Databáze: OpenAIRE